Stakeholder Survey: Tracking the Fate of Cell Therapy Products In Vivo

Part I - About you

This survey, conducted by the Cell Therapy - TRAcking, Circulation, & Safety Committee (CT-TRACS) at the Health and Environmental Sciences Institute (HESI), aims to understand various stakeholders' views in the field of medical cell tracking. We're particularly interested in the criteria for adopting cell tracking solutions, especially in the context of recent FDA investigations into CAR-T cell therapy. Please share your individual opinions, not your institution's official stance. The survey contains 20 questions and takes approximately 10 minutes.

Question Title

* 1. Please specify your educational background (Tick all that apply).

Medicine

Biology / Life Sciences / Biotechnology

Pharmaceutical Sciences

Chemistry

Physics

Engineering

Veterinary Medicine

Economics

Other (please specify)

Question Title

* 2. Please indicate your professional setting (Tick all that apply).

Academia / University

BioPharma / Biotech

Hospital / Clinic

Government

Regulator

CRO / CMO / CDMO

Non-Profit / NGO

Consulting

Other (please specify)

Question Title

* 3. What is your seniority level?

Student (before graduation)

Early scientist (0-3 years post graduation)

Scientist (3-6 years post graduation)

Professional (+ 6 years post graduation)

Key Opinion Leader (Senior physician, Manager, Director, VP, Department head or comparable)

Prefer not to say

Other (please specify)

Question Title

* 4. What are you most involved with?

Cell therapy product developer

Imaging technology developer

Cell therapy product user

Imaging technology user

Other (please specify)